Chiasma

Dedicated to addressing the everyday challenges associated with existing therapies for rare and serious chronic diseases.

Launch date

2001

Employees

Market cap

Enterprise valuation

€300m (Public information from May 2021)

Company register number 513104026

Jerusalem Jerusalem District (HQ)

https://chiasma.com/

https://twitter.com/chiasmapharma https://www.linkedin.com/company/chiasma_2

Authorizing premium user...